Hepatic steatosis in overweight/obese females: new screening method for those at risk.
OBJECTIVE
To identify which parameters could help to distinguish the "metabolically benign obesity", which is not accompanied by insulin resistance (IR) and early atherosclerosis.


METHODS
Eighty two of 124 overweight/obese females formed the study population, which was divided into two groups (52 and 30 subjects, respectively) with and without IR according to a HO meostatic Metabolic Assessment (HOMA) cut-off of 2, and were studied in a cross-sectional manner. The main outcome measures were waist circumference, serum uric acid, high-density lipoprotein-cholesterol and triglycerides, alanine aminotransferase, blood pressure and the two imaging parameters, hepatic steatosis and longitudinal diameter of the spleen, which were measured in relation to the presence/absence of IR.


RESULTS
A variable grade of visceral obesity was observed in all subjects with the exception of three. Obesity of a severe grade was represented more in the group of IR individuals (P = 0.01). Hepatic steatosis, revealed at ultrasound, was more pronounced in IR than in non-IR subjects (P = 0.005). The two groups also demonstrated a clear difference in longitudinal spleen diameter and blood pressure, with raised and significant values in the IR group. Metabolic syndrome was frequent in the IR group, and was not modified when adjusted for menopause (P = 0.001). At linear regression, the beta values of waist circumference and body mass index predicting HOMA were 0.295, P = 0.007 and 0.41, P = 0.0001, respectively. Measures of spleen longitudinal diameter were well predicted by body mass index (BMI) values, beta = 0.35, P = 0.01, and by HOMA, beta = 0.41, P = 0.0001. Blood pressure was predicted by HOMA values, beta = 0.39, P = 0.0001). HOMA and hepatic steatosis were highly associated (rho = 0.34, P = 0.002). Interestingly, IR patients were almost twice as likely to have hepatic steatosis as non-IR patients. Among the MS criteria, blood pressure was very accurate in identifying the presence of IR (AUROC for systolic blood pressure 0.66, cut-off 125 mm of Hg, sensibility 64%, specificity 75%; AUROC for diastolic blood pressure 0.70, cut-off 85 mm of Hg, sensibility 54.5%, specificity 75%).


CONCLUSIONS
As health care costs are skyrocketing, reliable and mainly inexpensive tools are advisable to better define subjects who really need to lose weight.
Tarantino
Giovanni
G
Department of Clinical and Experimental Medicine, Section of Hepatology in Internal Medicine, Federico II University Medical School of Naples, Naples, Italy. tarantin@unina.it
Pizza
Genoveffa
G
Colao
Annamaria
A
Pasanisi
Fabrizio
F
Conca
Paolo
P
Colicchio
Patrizia
P
Finelli
Carmine
C
Contaldo
Franco
F
Di Somma
Carolina
C
Savastano
Silvia
S
D000293:Adolescent; D000328:Adult; D050197:Atherosclerosis / Q000209:etiology; D001794:Blood Pressure / Q000502:physiology; D015992:Body Mass Index; D001835:Body Weight; D005234:Fatty Liver / Q000209:etiology / Q000517:prevention & control; D005260:Female; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology; D008297:Male; D008403:Mass Screening / Q000379:methods*; D024821:Metabolic Syndrome / Q000209:etiology; D008875:Middle Aged; D009765:Obesity / Q000150:complications / Q000473:pathology / Q000503:physiopathology; D050177:Overweight / Q000150:complications / Q000473:pathology / Q000503:physiopathology; D013154:Spleen / Q000033:anatomy & histology / Q000000981:diagnostic imaging; D014463:Ultrasonography; D055815:Young Adult